HTG Molecular Diagnostics, Inc. (HTGM:NASDAQ) Investor Relations Material

Overview

Arizona-based HTG Molecular Diagnostics, Inc. is a life sciences company with a precise focus on medicine. According to their website, the company offers a range of instruments, consumables, and software that automate sample processing and profiles various molecular targets. Notable among its marketed molecular profiling panels are the HTG Transcriptome Panel, HTG EdgeSeq precision immuno-oncology panel, and HTG EdgeSeq miRNA whole-transcriptome assay. The company distributes its instruments and consumables in the US and Europe (either directly, or via distributors), and internationally. Its customer base, meanwhile, consists of biopharmaceutical companies, academic research centers, and molecular testing laboratories. The company, which has undergone a name change to HTG Molecular Diagnostics, Inc., was incorporated in 1997 under the name HTG, Inc.

Frequently Asked Questions

What is HTG Molecular Diagnostics, Inc.'s ticker?

HTG Molecular Diagnostics, Inc.'s ticker is HTGM

What exchange is HTG Molecular Diagnostics, Inc. traded on?

The company's shares trade on the NASDAQ stock exchange

Where are HTG Molecular Diagnostics, Inc.'s headquarters?

They are based in Tucson, Arizona

How many employees does HTG Molecular Diagnostics, Inc. have?

There are 51-200 employees working at HTG Molecular Diagnostics, Inc.

What is HTG Molecular Diagnostics, Inc.'s website?

It is http://www.htgmolecular.com/

What type of sector is HTG Molecular Diagnostics, Inc.?

HTG Molecular Diagnostics, Inc. is in the Healthcare sector

What type of industry is HTG Molecular Diagnostics, Inc.?

HTG Molecular Diagnostics, Inc. is in the Biotechnology industry

Who are HTG Molecular Diagnostics, Inc.'s peers and competitors?

The following five companies are HTG Molecular Diagnostics, Inc.'s industry peers:

- Sangamo Therapeutics

- Phio Pharmaceuticals Corp.

- CASI Pharmaceuticals Inc

- Choice Properties REIT

- KalVista Pharmaceuticals, Inc.